BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28157407)

  • 1. The Impact of New Technologic and Molecular Advances in the Daily Practice of Gastrointestinal and Hepatobiliary Pathology.
    Xue Y; Farris AB; Quigley B; Krasinskas A
    Arch Pathol Lab Med; 2017 Apr; 141(4):517-527. PubMed ID: 28157407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Developments in Breast Cancer and Their Impact on Daily Practice in Pathology.
    Li X; Oprea-Ilies GM; Krishnamurti U
    Arch Pathol Lab Med; 2017 Apr; 141(4):490-498. PubMed ID: 28353377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonneoplastic signet-ring cell change in gastrointestinal and biliary tracts: a pitfall for overdiagnosis.
    Dhingra S; Wang H
    Ann Diagn Pathol; 2011 Dec; 15(6):490-6. PubMed ID: 22082777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 14th Spring Seminar of the Korean Pathologists Association of North America.
    Lee EY; Yu E; Ro JY
    Arch Pathol Lab Med; 2016 May; 140(5):394-6. PubMed ID: 27128296
    [No Abstract]   [Full Text] [Related]  

  • 5. Pitfalls and Limitations of Radionuclide Hepatobiliary and Gastrointestinal System Imaging.
    Low CS; Ahmed H; Notghi A
    Semin Nucl Med; 2015 Nov; 45(6):513-29. PubMed ID: 26522393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary imaging of functional and morphological changes following hepatic arterial embolization in hepatocellular carcinoma.
    Tai DI; Chen HY; Wang PW; Lee CH; Lee TY; Chen WJ; Chen JJ; Chang Chien CS
    J Nucl Med; 1995 Sep; 36(9):1590-4. PubMed ID: 7658215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?].
    Ebert MP; Schmid RM
    Dtsch Med Wochenschr; 2009 Sep; 134(37):1835-7. PubMed ID: 19728255
    [No Abstract]   [Full Text] [Related]  

  • 8. Precision Medicine in Gastrointestinal Pathology.
    Wang DH; Park JY
    Arch Pathol Lab Med; 2016 May; 140(5):449-60. PubMed ID: 27128302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of bone, gallium and hepatobiliary scintigraphy in the detection of bone metastases in hepatoma].
    Tahara T; Ichiya Y; Kuwabara Y; Otsuka M; Masuda K
    Kaku Igaku; 1988 Dec; 25(12):1337-44. PubMed ID: 2854867
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
    J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of 99mTc-PMT delayed hepatobiliary imaging in small hepatocellular carcinoma--an analysis of 62 cases].
    Chen SL
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):30-2. PubMed ID: 1653687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
    Kilickap S; Arslan C; Senel S; Ataseven H
    J Clin Oncol; 2010 Feb; 28(6):e99; author reply e100. PubMed ID: 20085931
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in hepatobiliary pathology: update for 2010.
    Lefkowitch JH
    Clin Liver Dis; 2010 Nov; 14(4):747-62. PubMed ID: 21055694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective abdominal arteriography in gastrointestinal pathology].
    Guelrud M
    G E N; 1971; 26(1):97-139. PubMed ID: 4360625
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positron emission tomography and gastrointestinal oncology].
    Ducreux M; Taieb J; Boige V; Lasser P; Elias D; Lumbroso J
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B71-8. PubMed ID: 12843940
    [No Abstract]   [Full Text] [Related]  

  • 16. Preface: Updates and Challenges in Gastrointestinal Pathology.
    Gonzalez RS
    Surg Pathol Clin; 2020 Sep; 13(3):ix. PubMed ID: 32773200
    [No Abstract]   [Full Text] [Related]  

  • 17. [6. Inspection of Hepatocellular Carcinoma 4: Nuclear Medicine Scan].
    Odagiri H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jun; 72(6):522-9. PubMed ID: 27320156
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.
    Kim MN; Kim BK; Han KH; Kim SU
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):335-48. PubMed ID: 25370168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the hepatobiliary system using 99mTc-p-butyl-IDA].
    Zubovskiĭ GA; Ogneva TV
    Med Radiol (Mosk); 1982 Jan; 27(1):28-31. PubMed ID: 6977080
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.
    Chen ZE; Lin F
    Arch Pathol Lab Med; 2015 Jan; 139(1):14-23. PubMed ID: 25549141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.